Derivatization of genotoxic nitroaromatic impurities for trace analysis by LC-MS

Trace level analysis of genotoxic impurities requires highly sensitive analytical methodologies and poses a tremendous challenge for the pharmaceutical industry. Nitroaromatic compounds, among the genotoxic structural alerts, are widely used as starting materials or intermediates for the synthesis of active pharmaceutical ingredients (APIs). If their genotoxicities are confirmed, the nitroaromatic impurities need to be controlled under the Threshold of Toxicological Concern (TTC) level. In general, HPLC-UV methodology is not suitable due to the inadequate sensitivity of the UV detection. Many nitroaromatic compounds used in the pharmaceutical industry are non-volatile, and thus the application of GC is limited. If used directly, LC-MS methodology is less useful to neutral nitroaromatic compounds that lack ionization efficiency. In this article, the authors report a new methodology to detect and quantify trace nitroaromatic compounds by LC-MS after chemical derivatization, where the nitroaromatic compounds are reduced to the corresponding ionizable aromatic amines. It is the authors' hope to provide a general methodology for detecting and quantifying nitroaromatics at trace levels. The reported method is validated for sensitivity, linearity, precision and accuracy. This methodology has been successfully applied to one of Celgene's projects and the detailed case study is provided in this article.

[1]  Ann Thayer GENOTOXIC IMPURITIES: Faced with new guidelines that many find constraining, pharmaceutical manufacturers are seeking ways to avoid or reduce HARMFUL CONTAMINANTS in drugs , 2010 .

[2]  S. Gorog Drug safety, drug quality, drug analysis , 2008 .

[3]  D. Norwood,et al.  Identification of Pharmaceutical Impurities , 2007 .

[4]  Lutz Müller,et al.  A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[5]  Nigel Greene,et al.  The computational prediction of genotoxicity , 2010, Expert opinion on drug metabolism & toxicology.

[6]  David Q. Liu,et al.  Enhancing the detection sensitivity of trace analysis of pharmaceutical genotoxic impurities by chemical derivatization and coordination ion spray-mass spectrometry. , 2010, Journal of chromatography. A.

[7]  M. Aznar,et al.  Quantitative determination of 22 primary aromatic amines by cation-exchange solid-phase extraction and liquid chromatography-mass spectrometry. , 2009, Journal of chromatography. A.

[8]  David Q. Liu,et al.  A Systematic Method Development Strategy for Determination of Pharmaceutical Genotoxic Impurities , 2010 .

[9]  R. Ito,et al.  A new strategy for ionization enhancement by derivatization for mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  Ashok Kumar,et al.  Development and validation of UPLC method for determination of primaquine phosphate and its impurities. , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  David Q. Liu,et al.  Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process. , 2009, Journal of pharmaceutical and biomedical analysis.

[12]  David Q. Liu,et al.  Recent advances in trace analysis of pharmaceutical genotoxic impurities. , 2010, Journal of pharmaceutical and biomedical analysis.

[13]  David Q. Liu,et al.  Eliminating pharmaceutical impurities: Recent advances in detection techniques. , 2010, Current opinion in drug discovery & development.

[14]  H. Karnes,et al.  Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.